title: Surgical treatment and management of hip fracture patients.
abstract: BACKGROUND
  Osteoporosis-related hip fractures are associated with high mortality and costs. The optimum type of treatment for such fractures is controversial. To shed some light on this issue, the surgical treatment and management of osteoporotic hip fractures were discussed during a hip fracture surgical working group at the 2009 International Society For Fracture Repair Annual Meeting comprising leading experts in the field.
  
  
  METHODS
  The working group consisted of eight orthopaedic surgeons, six industry representatives and one research scientist. Eleven participants were from Europe and four were from the USA and Canada. Two chairmen posed 12 questions relating to the surgical treatment and management of osteoporotic hip fractures. Each question was discussed and key points were noted.
  
  
  RESULTS
  Surgery should commence within 24-48 h but the patient should be optimized if presenting with ≥3 comorbidities. Specialized centres integrating orthopaedics, geriatricians and rheumatologists could be a solution for the lack of specialist care post-surgery. Surgical technique is important in fracture fixation, as is the implant, but there has been no improvement in implant design in the past 50 years. As a consequence, malunion has become unjustifiably accepted. Fracture healing can be accelerated using pharmaceuticals which are also important in secondary prophylaxis. All displaced femoral neck fractures in geriatric patients should be treated with hip replacement, the choice between using cemented or uncemented fixation being at the surgeon's discretion.
  
  
  CONCLUSIONS
  This working group discussion highlighted several important issues which could be of interest to the orthopaedic community.
authors.affiliation: School of Sports Science, University of Bologna, Via G. C. Pupilli 1, 40136, Bologna, Italy, a.moroni@ior.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Moroni
authors.forename: Martha
authors.initials: M
authors.lastname: Hoque
authors.forename: James P
authors.initials: JP
authors.lastname: Waddell
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Russell
authors.forename: Burkhard
authors.initials: B
authors.lastname: Wippermann
authors.forename: Gary
authors.initials: G
authors.lastname: DiGiovanni
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019644:Arthroplasty, Replacement, Hip / Q000379:methods; D015897:Comorbidity; D005260:Female; D005265:Femoral Neck Fractures / Q000601:surgery; D017102:Fracture Healing / Q000187:drug effects; D050723:Fractures, Bone / Q000601:surgery; D006620:Hip Fractures / Q000601:surgery*; D006801:Humans; D008297:Male; D058866:Osteoporotic Fractures / Q000601:surgery; D055502:Secondary Prevention; D016896:Treatment Outcome